185 related articles for article (PubMed ID: 35191812)
21. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Liu C; Li J; Wang L; Wu F; Huang L; Xu Y; Ye J; Xiao B; Meng F; Chen S; Yang M
BMC Complement Altern Med; 2012 Jan; 12():5. PubMed ID: 22248096
[TBL] [Abstract][Full Text] [Related]
22. Tanshinone IIA exerts therapeutic effects by acting on endogenous stem cells in rats with liver cirrhosis.
Yang N; Chen H; Gao Y; Zhang S; Lin Q; Ji X; Li N; Xu W; Liu Y; Jin S
Biomed Pharmacother; 2020 Dec; 132():110815. PubMed ID: 33113421
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
[No Abstract] [Full Text] [Related]
24. Tanshinone IIA regulates glycogen synthase kinase-3β-related signaling pathway and ameliorates memory impairment in APP/PS1 transgenic mice.
Peng X; Chen L; Wang Z; He Y; Ruganzu JB; Guo H; Zhang X; Ji S; Zheng L; Yang W
Eur J Pharmacol; 2022 Mar; 918():174772. PubMed ID: 35090935
[TBL] [Abstract][Full Text] [Related]
25. Tanshinone-induced ERs suppresses IGFII activation to alleviate Ang II-mediated cardiac hypertrophy.
Chen YF; Lee NH; Pai PY; Chung LC; Shen CY; Rajendran P; Chen YF; Chen RJ; Padma Viswanadha V; Kuo WW; Huang CY
J Recept Signal Transduct Res; 2017 Oct; 37(5):493-499. PubMed ID: 28812967
[TBL] [Abstract][Full Text] [Related]
26. Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts.
Chan P; Liu JC; Lin LJ; Chen PY; Cheng TH; Lin JG; Hong HJ
Am J Chin Med; 2011; 39(2):381-94. PubMed ID: 21476213
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-27 attenuates pressure overload-Induced cardiac hypertrophy and dysfunction by targeting galectin-3.
Zhang M; Cheng K; Chen H; Tu J; Shen Y; Pang L; Wu W
Arch Biochem Biophys; 2020 Aug; 689():108405. PubMed ID: 32439330
[TBL] [Abstract][Full Text] [Related]
28. Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells.
Takahashi K; Ouyang X; Komatsu K; Nakamura N; Hattori M; Baba A; Azuma J
Biochem Pharmacol; 2002 Aug; 64(4):745-9. PubMed ID: 12167494
[TBL] [Abstract][Full Text] [Related]
29. Antifatigue properties of tanshinone IIA in mice subjected to the forced swimming test.
Lin CY; Jhang YS; Lai SC; Chen EL; Lin IH; Chang TW; Tseng YW; Seenan V; Shiung J; Chen MH; Chiang YC; Chen TI; Tzeng YJ
Pharm Biol; 2017 Dec; 55(1):2264-2269. PubMed ID: 29171356
[TBL] [Abstract][Full Text] [Related]
30. A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza.
Cui S; Chen S; Wu Q; Chen T; Li S
Int Immunopharmacol; 2020 Apr; 81():106040. PubMed ID: 31818704
[TBL] [Abstract][Full Text] [Related]
31. Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.
Won SH; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Jung DB; Shin JM; Kwon TR; Yun SM; Lee MH; Choi SH; Lü J; Kim SH
Biol Pharm Bull; 2010; 33(11):1828-34. PubMed ID: 21048307
[TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA protected against lipopolysaccharide-induced brain injury through the protective effect of the blood-brain barrier and the suppression of oxidant stress and inflammatory response.
Wang X; Wang WM; Han H; Zhang Y; Liu JL; Yu JY; Liu HM; Liu XT; Shan H; Wu SC
Food Funct; 2022 Aug; 13(15):8304-8312. PubMed ID: 35839080
[TBL] [Abstract][Full Text] [Related]
33. The quality of wild Salvia miltiorrhiza from Dao Di area in China and its correlation with soil parameters and climate factors.
Liang H; Kong Y; Chen W; Wang X; Jia Z; Dai Y; Yang X
Phytochem Anal; 2021 May; 32(3):318-325. PubMed ID: 32761717
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models.
Buenafe OE; Orellana-Paucar A; Maes J; Huang H; Ying X; De Borggraeve W; Crawford AD; Luyten W; Esguerra CV; de Witte P
ACS Chem Neurosci; 2013 Nov; 4(11):1479-87. PubMed ID: 23937066
[TBL] [Abstract][Full Text] [Related]
35. Tanshinone IIA improves degranulation of mast cells and allergic rhinitis induced by ovalbumin by inhibiting the PLCγ1/PKC/IP3R pathway.
Li S; Li Z; Tan T; Dai S; Wu Y; Xu F
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S702-S710. PubMed ID: 34792426
[TBL] [Abstract][Full Text] [Related]
36. Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer.
Liu Z; Zhu W; Kong X; Chen X; Sun X; Zhang W; Zhang R
Oncol Rep; 2019 Nov; 42(5):1893-1903. PubMed ID: 31485631
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of tanshinone IIA on renin activity protected against osteoporosis in diabetic mice.
Zhang J; Cai Z; Yang M; Tong L; Zhang Y
Pharm Biol; 2020 Dec; 58(1):219-224. PubMed ID: 32202179
[No Abstract] [Full Text] [Related]
38. Prospective therapeutic potential of Tanshinone IIA: An updated overview.
Ansari MA; Khan FB; Safdari HA; Almatroudi A; Alzohairy MA; Safdari M; Amirizadeh M; Rehman S; Equbal MJ; Hoque M
Pharmacol Res; 2021 Feb; 164():105364. PubMed ID: 33285229
[TBL] [Abstract][Full Text] [Related]
39. Tanshinone IIA protects against cardiac fibrosis through inhibition of β-tubulin expression.
Zhang Y; Zhang S; Chen X
J Biol Regul Homeost Agents; 2018; 32(6):1451-1455. PubMed ID: 30574749
[TBL] [Abstract][Full Text] [Related]
40. Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats.
Wang D; Yu W; Cao L; Xu C; Tan G; Zhao Z; Huang M; Jin J
Biopharm Drug Dispos; 2020 Feb; 41(1-2):54-63. PubMed ID: 31943245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
